Privium Fund Management B.V. Horizon Therapeutics Public LTD CO Transaction History

Privium Fund Management B.V.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 25, 2023	BUY	$96.34 - $112.38 $2.16 Million - $2.52 Million	22,447 New	22,447 $2.31 Million
Q2 2022 Jul 28, 2022	SELL	$79.4 - $116.36 $2.38 Million - $3.49 Million	-30,000 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$86.42 - $109.81 $2.59 Million - $3.29 Million	30,000 New	30,000 $3.16 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Privium Fund Management B.V., based on Form 13F filings with the SEC.

Stay updated on Privium Fund Management B.V. with notifications on news.